Member

Verasio

Verasio is developing a continuous blood monitoring platform designed to provide high-frequency measurement and trending of clinically relevant blood biomarkers directly at the bedside. Our goal is to enable earlier recognition of physiologic deterioration while reducing reliance on intermittent blood draws and providing critical information when centralized laboratory testing is delayed, limited, or unavailable. The platform is initially being developed for critical care, with potential military applications including combat casualty care, en-route care, prolonged casualty care, sepsis management and hemorrhage and shock management.

Industries

Medical Device

Physiologic Monitoring

Critical Care

Diagnostics

Nr. of Employees

small (1-50)

Verasio

https://verasio.com

kyle@verasio.com

(415) 244-7566

Verasio is currently seeking investment

Verasio is seeking a pre-seed investment in the range of 1m-5m

All Investment-seeking Members

Products

Continuous Blood Monitoring Platform

A portable bedside platform in development for high-frequency monitoring and trending of clinically relevant blood biomarkers, designed to provide actionable physiologic information when conventional laboratory measurements are intermittent, delayed, or unavailable. The system is designed around a reusable monitoring platform with a disposable sensing cartridge. Potential applications include critical care, casualty stabilization, en-route care, and prolonged casualty care.